Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Electroconvulsive Therapy01:30

Electroconvulsive Therapy

93
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
93
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

234
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
234
Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

275
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
275
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

173
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
173
Bipolar Disorder01:30

Bipolar Disorder

109
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
109
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

58
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
58

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Kynurenine pathway profiles as markers of ketamine response in treatment-resistant depression.

Brain, behavior, and immunity·2026
Same author

Baseline inflammatory profiles in moderate-to-severe depression and differential response to intermittent theta-burst stimulation.

Progress in neuro-psychopharmacology & biological psychiatry·2026
Same author

Electroconvulsive therapy in Germany: a nationwide multilevel analysis of determinants, regional patterns, and institutional variation.

European archives of psychiatry and clinical neuroscience·2026
Same author

A unified voice for evidence-based psychiatry: a global response to the WHO guidance on ECT.

European archives of psychiatry and clinical neuroscience·2026
Same author

Just a caffeine-blocker? Questioning new proposed core mechanisms of ECT.

Brain stimulation·2026
Same author

Joint statement by the World Psychiatric Association, the American Psychiatric Association, the European Psychiatric Association, and the Global Expert Task Force on ECT on the portrayal of electroconvulsive therapy in the WHO Guidance on Mental Health Policy and Strategic Action Plans.

The lancet. Psychiatry·2026

Related Experiment Video

Updated: Aug 2, 2025

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
09:07

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins

Published on: August 15, 2017

12.1K

Catatonia and ECT across the lifespan.

Sebastian Karl1, Alexander Sartorius1, Suna Su Aksay1

  • 1Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, J5, 68159 Mannheim, Germany.

Schizophrenia Research
|April 22, 2023
PubMed
Summary

Electroconvulsive therapy (ECT) is a safe and effective treatment for catatonia across all age groups. Despite some challenges, evidence supports its use in children, adolescents, and geriatric patients.

Keywords:
AdolescentCatatoniaElderlyElectroconvulsive therapyGeriatric

More Related Videos

Pupillary Response as Assessment of Effective Seizure Induction by Electroconvulsive Therapy
04:51

Pupillary Response as Assessment of Effective Seizure Induction by Electroconvulsive Therapy

Published on: April 11, 2019

9.5K
Chronic Transcranial Electrical Stimulation and Intracortical Recording in Rats
10:51

Chronic Transcranial Electrical Stimulation and Intracortical Recording in Rats

Published on: May 11, 2018

8.8K

Related Experiment Videos

Last Updated: Aug 2, 2025

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
09:07

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins

Published on: August 15, 2017

12.1K
Pupillary Response as Assessment of Effective Seizure Induction by Electroconvulsive Therapy
04:51

Pupillary Response as Assessment of Effective Seizure Induction by Electroconvulsive Therapy

Published on: April 11, 2019

9.5K
Chronic Transcranial Electrical Stimulation and Intracortical Recording in Rats
10:51

Chronic Transcranial Electrical Stimulation and Intracortical Recording in Rats

Published on: May 11, 2018

8.8K

Area of Science:

  • Neuroscience
  • Psychiatry
  • Clinical Medicine

Background:

  • Catatonia is a complex neuropsychiatric syndrome.
  • Electroconvulsive therapy (ECT) is a recognized treatment for catatonia.
  • Concerns exist regarding ECT use in pediatric, adolescent, and geriatric populations.

Purpose of the Study:

  • To explore barriers to ECT use in children, adolescents, and geriatric patients with catatonia.
  • To provide an overview of ECT for catatonia treatment in these age groups.
  • To offer practical guidance for administering ECT to pediatric, adolescent, and geriatric catatonia patients.

Main Methods:

  • Review of existing literature on ECT for catatonia.
  • Analysis of challenges in diagnosing and treating catatonia in specific age groups.
  • Discussion of safety and efficacy data across the lifespan.

Main Results:

  • ECT demonstrates high response rates and safety in treating catatonia.
  • Underdiagnosis of catatonia may occur due to its classification and overlap with other conditions.
  • Empirical data indicate comparable tolerability and efficacy to adult treatments.

Conclusions:

  • Electroconvulsive therapy is a safe and effective treatment for catatonia throughout life.
  • Existing evidence does not justify restricting ECT use based on age.
  • Practical considerations are necessary for administering ECT in younger and older patients.